Partnership opportunities - Britannia Pharmaceuticals

Brand	Drug Name	Indication	Partnership

ANP	Apomorphine nasal powder	Parkinson's disease/ erectile dysfunction	Pfeiffer Delivery device collaboration
APO-go	Apomorphine hydrochloride	Parkinson's disease	Apotheekzorg Marketing in Benelux countries
APO-go	Apomorphine hydrochloride	Parkinson's disease	Cané Infusion technology collaboration
APO-go	Apomorphine hydrochloride	Parkinson's disease	Cephalon Marketing in Germany, Austria and Switzerland
APO-go	Apomorphine hydrochloride	Parkinson's disease	Clonmel Healthcare Marketing in the Republic of Ireland
APO-go	Apomorphine hydrochloride	Parkinson's disease	Gen Ilac Marketing in Turkey
APO-go	Apomorphine hydrochloride	Parkinson's disease	Italfarmaco Marketing in Spain and Portugal
APO-go	Apomorphine hydrochloride	Parkinson's disease	Intimex Marketing in Slovenia and the Czech Republic
APO-go	Apomorphine hydrochloride	Parkinson's disease	ITF Hellas Marketing in Greece
APO-go	Apomorphine hydrochloride	Parkinson's disease	Kyowa Hakko Marketing and development in Japan
APO-go	Apomorphine hydrochloride	Parkinson's disease	Mayne Pharma Marketing in Australia
APO-go	Apomorphine hydrochloride	Parkinson's disease	NordicInfu Care Marketing in Scandinavian countries
APO-go	Apomorphine hydrochloride	Parkinson's disease	Teva Marketing in Israel
APO-go	Apomorphine hydrochloride	Parkinson's disease	Vernalis Development and marketing in North America
DNP	DHE nasal powder	Acute treatment of Migraine	Pfeiffer Delivery device collaboration
BritLofex	Lofexidine hydrochloride	Opiate detoxification	Clonmel Healthcare Distribution in the Republic of Ireland
BritLofex	Lofexidine hydrochloride	Opiate detoxification	US WorldMeds Development and marketing in North America
Adsurf	Pumactant	Surgical Adhesions	Bespak Delivery device collaboration
PADD	Pumactant	Pressurised aerosol dry-powder delivery	AirPharma Worldwide development and marketing
Zofac	Pumactant	Asthma	AirPharma Worldwide development and marketing